We used a global Fam114a1-KO mouse model to demonstrate that deletion of FAM114A1 antagonizes pathological cardiac remodeling, including cardiac fibrosis, CM hypertrophy, and inflammation in vivo using Ang II and MI models. This evidence concerns the gene FAM114A1 and myocardial infarction.